12 Biotech M&A deals in Q1 totaling $19 bil on similar pace with 2022...
M&A in Q1 alone totaled 12 deals for $19.2 bil which is close to the 10 deals for $21.9 bil in all the 1H of 2023...
But one big caveat of this chart, it doesn't include $Pfizer(PFE.US$ 's $43 bil deal for $SGEN announced in Mar 2023 but didn't close until Dec bc of an FTC challenge,
The biggest biotech M&A deal so far this yr was $Gilead Sciences(GILD.US$ 's $4.3 bil buyout of $CBAY,
Bolt-on deals will likely be preferred over mega deals (>$15 bil) that draw scrutiny from regulators, especially in an election yr where drug prices (IRA) will continue to be in focus.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment